mercredi 6 janvier 2016

Onco Actu du 6 janvier 2016


1. Biologie

Missing mice: gaps in data plague animal research [Nature News & Comment]

2. Etiologie

When one twin gets cancer, other faces higher risk [Harvard Gazette]

Study of twins sheds light on how genetics impacts cancer risk [STAT]

3. Prévention

Grand Challenge three: prevent cancer by studying ‘scars’ in its DNA [Cancer Research UK]

3.1 Tabac

Advertising may be fueling the popularity of e-cigarettes among teens, CDC says [LA Times]

E-cigarette ads' wide reach among U.S. youth alarming: CDC [Reuters]

3.3 Prévention - Vaccins

Male HPV Vaccination Scheme Launch [British Medical Association]

5. Traitements

Exercise could work as treatment for prostate cancer [Cancer Research UK]

5.10 Traitements - Essais

Improving access to clinial trials when biopsies are required [IASLC]

5.12 Immunothérapies

Celyad completes 30-day safety follow-up of first patient of second cohort in NKG2D CAR T-Cell Phase I Trial [Celyad]

5.2.1 Pharma - Partenariats

Bristol-Myers taps Oncodesign to serve up targets for new cancer drugs [FierceBiotech]

5.5 ASCO

Highlights of 2016 ASCO Genitourinary Cancers Symposium [The OBR Blog]

Circulating Tumor Cells Linked with Treatment Resistance and Response in Prostate Cancer Patients [Epic Sciences]

New Blood Test Technology Shows Promise for Guiding Prostate Cancer Treatment Decisions [ASCO]

Cabozantinib Improves Upon the Standard of Care for Advanced Kidney Cancer [ASCO]

Regular Aspirin Use May Reduce Risk of Dying From Prostate Cancer [ASCO]

6. Lutte contre les cancers

Oncology’s Future: Liquid Biopsies and the Heterogeneity of Cancer [Xconomy]

6.4 Médico-éco

For working-age cancer survivors, debt and bankruptcy are common [Reuters]

6.6 Publications

The ORCID mantra for 2016: Sustain, Lead, and Mature [ORCID]

At the heart of reproducibility lies the problem of transparency [Scope]

Reproducible Research Practices and Transparency across the Biomedical Literature [PLOS Biology]